Understanding AI's Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci

Understanding AI's Expanding Role in Drug Dis...

Up next

AI Use Cases, Deployment, and Measuring Real-World ROI - with Ylan Kazi of Blue Cross Blue Shield of North Dakota

Today's guest is Ylan Kazi, Chief Data and AI Officer at Blue Cross Blue Shield of North Dakota. With deep experience leading enterprise AI strategy in regulated healthcare, Ylan brings a grounded perspective on how organizations can innovate responsibly with emerging technology. ...  Show more

Operationalizing Customer Service at Scale with Outcome-Driven Agentic AI - with Craig Walker of Dialpad

Customer service leaders face rising pressure to resolve more interactions faster, while maintaining high-quality experiences — and many legacy systems and processes can't keep up. In this episode, Craig Walker, CEO of Dialpad, joins Daniel Faggella, Emerj CEO and Head of Researc ...  Show more

Recommended Episodes

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

How AI is saving billions of years of human research time | Max Jaderberg
TED Tech

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ...  Show more

Isomorphic Labs Discusses AI-Driven Drug Discovery and the Future of Medicine - Ep. 252
NVIDIA AI Podcast

Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ...  Show more

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
NVIDIA AI Podcast

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more